Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Vesna Vargek Solter is active.

Publication


Featured researches published by Vesna Vargek Solter.


Annals of Saudi Medicine | 2007

Impact of hyperglycemia on ischemic stroke mortality in diabetic and non-diabetic patients.

Vanja Basic Kes; Vesna Vargek Solter; Višnja Supanc; Vida Demarin

BACKGROUND Previous studies suggest that infarct expansion may be responsible for increased mortality after stroke onset in patients with prolonged stress hyperglycemia. Therefore, we evaluated the influence of prolonged stress hyperglycemia on stroke mortality in patients with and without diabetes. PATIENTS AND METHODS For 630 stroke patients admitted to the neurological intensive care department within 24 hours of stroke onset, we correlated mean blood glucose levels (MBGL) at admission and 72 hours after admission in diabetic and non-diabetic patients with final outcome. Blood glucose levels higher then 6.1 mmol/L (121 mg/dL) were treated as hyperglycemia. RESULTS Of 630 patients (mean age 71 ± 6), 410 were non-diabetic (mortality, 25%) and 220 patients were diabetic (mortality, 20%). All patients who died within 28 days of hospitalization had prolonged hyperglycemia (at admission and after 72 hours, despite insulin therapy). The unadjusted relative risk of in-hospital mortality within 28 days for all stroke patients was 0.68 (95% CI, 0.14–1.9) for non-diabetic patients and 0.39 (95% CI, 0.27–1.56) for diabetic patients. The unadjusted relative risk of in-hospital mortality within 28 days in ischemic stroke in patients with MBGL > 6.1–8.0 mmol/L (121–144 mg/dL) at admission and after 72 hours was 1.83 (95% CI, 0.41–5.5) for non-diabetic patients and 1.13 (95% CI, 0.78–4.5) for diabetic patients. Non-diabetic patients with hyperglycemia had a 1.7 times higher relative risk of in-hospital 28-day mortality than patients with diabetes. CONCLUSION Prolonged stress hyperglycemia in ischemic stroke patients increases the risk of in-hospital 28-day mortality, especially in non-diabetic patients.


Journal of Stroke & Cerebrovascular Diseases | 2014

The Role of Classic Risk Factors and Prothrombotic Factor Gene Mutations in Ischemic Stroke Risk Development in Young and Middle-Aged Individuals

Višnja Supanc; Zdenko Sonicki; Ines Vukasović; Vesna Vargek Solter; Iris Zavoreo; Vanja Bašić Kes

BACKGROUND In young individuals, a genetically predisposing hypercoagulability and classic modifying risk factors can act synergistically on the ischemic stroke risk development. The aim of the study was to compare the prevalence of classic vascular risk factors and polymorphisms of the G20210A coagulation factor II (prothrombin), Arg506Glu coagulation factor V Leiden, C677T methylenetetrahydrofolate reductase (MTHFR), and 4G/5G plasminogen activator inhibitor-1 (PAI-1) and the impact of these gene mutations and classic vascular risk factors on the overall stroke risk in individuals aged 55 years or younger. METHODS The study included 155 stroke patients aged 55 years or younger and 150 control subjects. Stroke prevalence and odds ratio (OR) were assessed for the following parameters: G20210A prothrombin, Arg506Glu factor V Leiden, C677T MTHFR, and 4G/5G PAI-1 polymorphisms; total number of study polymorphisms in a particular subject (genetic sum); and classic vascular risk factors of hypertension, obesity, diabetes mellitus, cigarette smoking, hypercholesterolemia, hypertriglyceridemia, and elevated levels of low-density lipoprotein (LDL) cholesterol and very low-density lipoprotein cholesterol. RESULTS The prevalence of hypertension (P < .001), smoking (P < .001), decreased HDL cholesterol levels (P < .001), obesity (P = .001), elevated LDL cholesterol (P = .036), C677T MTHFR polymorphism (P < .001), and genetic sum was significantly higher in the group of stroke patients. The following parameters were found to act as independent risk factors for ischemic stroke: decreased HDL cholesterol level (P < .001; OR 4.618; 95% confidence interval [CI] 2.381-8.957); hypertension (P = .001; OR 2.839; 95% CI 1.519-5.305); obesity (P = .040; OR 2.148; 95% CI 1.036-4.457); smoking (P = .001; OR 2.502; 95% CI 1.436-4.359); and genetic sum as a continuous variable (P < .01; OR 2.307; 95% CI 1.638-3.250). CONCLUSIONS Gene mutations of the procoagulable and proatherosclerotic factors investigated exerted a synergistic action in the development of overall risk of ischemic stroke in young and middle-aged individuals.


Acta Clinica Croatica | 2006

Recommendations for Stroke Management 2006 Update

Vida Demarin; Arijana Lovrenčić-Huzjan; Zlatko Trkanjec; Vlatka Vuković; Vesna Vargek Solter; Vesna Šerić; Ivo Lušić; Dragutin Kadojić; Ivan Bielen; Lidija Tuškan-Mohar; Anka Aleksić-Shibabi; Marinko Dikanović; Josip Hat; Drago DeSyo; Velimir Lupret; Vili Beroš


Collegium Antropologicum | 2004

Ultrasound Measurement of the Volume of Musculus Quadriceps after Knee Joint Injury

Melita Uremović; Marija Bošnjak Pašić; Vesna Šerić; Vesna Vargek Solter; Renata Budić; Branka Bošnjak; Selma Cvijetic-Avdagic; Darko Solter; Vida Demarin


Acta Clinica Croatica | 2012

Evidence Based Guidelines for Treatment of Primary Headaches – 2012 Update

Vlasta Vuković Cvetković; Vanja Bašić Kes; Vesna Šerić; Vesna Vargek Solter; Vida Demarin; Davor Jančuljak; Damir Petravić; Darija Mahović Lakušić; Sanja Hajnšek; Ivo Lušić; Ivan Bielen; Silvio Bašić; Davor Sporiš; Silva Soldo Butković; Igor Antončić


Acta Clinica Croatica | 2012

Recommendations for diagnosis and management of multiple sclerosis.

Vanja Bašić Kes; Iris Zavoreo; Vesna Šerić; Vesna Vargek Solter; Marijan Cesarik; Sanja Hajnšek; Marija Bošnjak Pašić; Tereza Gabelić; Silvio Bašić; Silva Soldo Butković; Ivo Lušić; Lidija Dežmalj Grbelja; Ante Vladić; Ivan Bielen; Igor Antončić; Vida Demarin


Acta Clinica Croatica | 2012

Report of the Croatian Society for Neurovascular Disorders, Croatian Medical Association. Evidence based guidelines for treatment of primary headaches--2012 update.

Vlasta Vuković Cvetković; Vanja Bašić Kes; Vesna Šerić; Vesna Vargek Solter; Vida Demarin; Davor Jančuljak; Damir Petravić; Darija Mahović Lakušić; Sanja Hajnšek; Ivo Lušić; Ivan Bielen; Silvio Bašić; Davor Sporiš; Silva Butković Soldo; Igor Antončić


Acta Clinica Croatica | 2006

Johann Sebastian Bach's Strokes

Tomislav Breitenfeld; Vesna Vargek Solter; Darko Breitenfeld; Iris Zavoreo; Vida Demarin


Acta Clinica Croatica | 2013

Guidelines for diagnosis, therapy and follow up of Anderson-Fabry disease.

Vanja Bašić Kes; Marijan Cesarik; Iris Zavoreo; Silva Soldo-Butković; Petar Kes; Nikolina Bašić-Jukić; Sanjin Rački; Marko Jakić; Diana Delić-Brkljačić; Zlatica Jukić; Zlatko Trkanjec; Serić; Vesna Vargek Solter; Ivan Bielen; Silvio Bašić; Demarin


Acta Clinica Croatica | 2014

ReCommendAtions foR tHe mAnAgement of mediCAl CompliCAtions in pAtients following AneuRysmAl subARACHnoid HemoRRHAge

Vesna Vargek Solter; Marina Roje-Bedeković; Tomislav Breitenfeld; Višnja Supanc; Arijana Lovrenčić-Huzjan; Vesna Šerić; Igor Antončić; Silvio Bašić; Vili Beroš; Ivan Bielen; Silva Butković Soldo; Dragutin Kadojić; Ivo Lušić; Branka Maldini; Anton Marović; Josip Paladino; Zdravka Poljaković; Branko Radanović; Marko Radoš; Krešimir Rotim; Miroslav Vukić; Dijana Zadravec; Vanja Bašić Kes

Collaboration


Dive into the Vesna Vargek Solter's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Vanja Bašić Kes

University Hospital Centre Zagreb

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marija Bošnjak Pašić

Josip Juraj Strossmayer University of Osijek

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge